Others Products Targets
- Voltage-gated Sodium (NaV) Channel (30)
- Voltage-gated Potassium (KV) Channel (38)
- Voltage-gated Calcium Channel (CaV) (38)
- TRPV (30)
- NFKB and IKB (30)
- GABAB Receptor (28)
- Lipoxygenase (8)
- Leukotriene and Related Receptor (13)
- Bradykinin Receptor (12)
- Others (20)
- Glucocorticoid Receptor (9)
- Cytokine Receptor (4)
- Cyclooxygenase (24)
- IRAK (1)
- NK2 Receptor (7)
- NK1 Receptor (15)
- NOP Receptor (21)
- Mu-Opioid Receptors (15)
- Kappa Opioid Receptors (14)
- Glutamate (Metabotropic) Group III Receptor (26)
- Glutamate (Metabotropic) Group II Receptor (33)
- Glutamate (Metabotropic) Group I Receptor (54)
- AMPA Receptor (45)
- GABAA-ρ Receptor (8)
- GABAA Receptor (66)
- GPR55 (8)
- CB2 Receptor (6)
- CB1 Receptor (17)
- Nicotinic (α7) Receptor (25)
- Nicotinic (α4β2) Receptor (14)
- NK3 Receptor (5)
- NMDA Receptor (87)
- Kainate Receptor (22)
- CCK2 Receptor (7)
- CCK1 Receptor (3)
- NO donors and precursors (9)
- nNOS (5)
- iNOS (11)
- eNOS (1)
- Delta opioid receptor (16)
- Purinergic (P2X) Receptor (32)
- Prostanoid Receptor (24)
Products for Others - Page 36
- Cat.No. Product Name Information/Activity
-
BCC6065
Hemopressin (human, mouse)
1314035-51-2
-
BCC5807
Hemopressin (rat)
568588-77-2
-
BCC7346
LY 320135
176977-56-3
-
BCC7852
MJ 15
944154-76-1
-
BCC7810
NIDA 41020
502486-89-7
-
BCC7746
PF 514273
851728-60-4
-
BCC7954
(±)-SLV 319
(±)-Ibipinabant ((±)-SLV319) is the racemate of SLV319. (±)-Ibipinabant ((±)-SLV319) is a potent and selective cannabinoid-1 (CB-1) receptor antagonist with an IC50 of 22 nM.
-
BCC1898
Rimonabant hydrochloride
Rimonabant hHydrochloride (SR 141716A Hydrochloride) is a highly potent and selective central cannabinoid receptor (CB1) antagonist with an Ki of 1.8 nM. Rimonabant hHydrochloride (SR 141716A Hydrochloride) also inhibits Mycobacterial membrane protein Large 3 (MMPL3).
-
BCC6144
TC-C 14G
656804-72-7
-
BCC4411
Org 27569
Org 27569 is a potent CB1 receptor allosteric modulator, which increases agonist binding, yet blocks agonist-induced CB1 signaling.
